Receptor News and Research

RSS
Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

15 Mar 2022
Mason scientists receive DOD funding for breast cancer prevention and treatment research

Mason scientists receive DOD funding for breast cancer prevention and treatment research

15 Mar 2022
Sustainable material-based biosensors for SARS-CoV-2 detection

Sustainable material-based biosensors for SARS-CoV-2 detection

15 Mar 2022
Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

14 Mar 2022
Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

14 Mar 2022
Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

14 Mar 2022
Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

14 Mar 2022
Conformational variation of the SARS-CoV-2 energy landscape

Conformational variation of the SARS-CoV-2 energy landscape

14 Mar 2022
Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

14 Mar 2022
Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

14 Mar 2022
In silico screening of natural ACE2 inhibitors

In silico screening of natural ACE2 inhibitors

14 Mar 2022
Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

14 Mar 2022
Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

14 Mar 2022
New insight about how blood clots are formed during wound healing

New insight about how blood clots are formed during wound healing

11 Mar 2022
Study may provide insight into the evolution of D-amino acid function in marine invertebrates

Study may provide insight into the evolution of D-amino acid function in marine invertebrates

11 Mar 2022
Mice study shows how to improve long-term effectiveness of TB vaccine

Mice study shows how to improve long-term effectiveness of TB vaccine

11 Mar 2022
Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

11 Mar 2022
In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

11 Mar 2022
Novel genetic relationships with severe SARS-CoV-2

Novel genetic relationships with severe SARS-CoV-2

11 Mar 2022
Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

11 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback